Being married triples the risk of obesity in men, research suggests. Experts found the risks of being overweight increase for both sexes when married, but appear to be particularly acute for men.The ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring orthopedic care.

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...

The prevalence of obesity and diabetes has grown worldwide, presenting notable challenges to public health and health care ...

One cup of frozen mixed berries provides 6 grams of fiber and is rich in antioxidants, including anthocyanins. Anthocyanins ...

The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide, the active ingredient in Ozempic and Wegovy, two prescription medications ...

Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...

Shares of Altimmune (NASDAQ:ALT) traded sharply higher on Friday after the obesity drug developer generated buyout rumors on ...

The Olean Times Herald mobile app brings you the latest local breaking news, updates, and more. Read the Olean Times Herald ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...